Literature DB >> 677138

Food and Drug Administration's adverse drug reaction monitoring program.

B Lee, W M Turner.   

Abstract

The adverse drug reaction monitoring program of the Division of Drug Experience within the FDA is described. Historical information on the development and activities of the current drug reaction monitoring program, and goals and objectives of the current program are discussed. Also presented are a brief description of the Voluntary Reporting System, intensive drug monitoring studies and special epidemiologic studies, and a workable definition of alert reports and examples of their previous role within the FDA. Pharmacists should participate actively in adverse drug reaction monitoring.

Mesh:

Year:  1978        PMID: 677138

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  2 in total

1.  Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.

Authors:  A C Rossi; J P Hsu; G A Faich
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

2.  The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.

Authors:  Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.